Ginkgo Bioworks Acquires Bitome to Accelerate the Path to Production-Ready Organisms.

MANews-(C)2009-2022

Massachusetts, US-based cell programming platform Ginkgo Bioworks (NYSE: DNA) has acquired certain assets from Boston-based integrated metabolite monitoring platform Bitome, to accelerate the path to production-ready organisms, the company said.

Terms of the transaction were not disclosed.

Bitome's continuous metabolite monitoring technology can support the accelerated product development timelines across Ginkgo's portfolio of cell programmes, the company said.

Ginkgo Bioworks is building a...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT